论文部分内容阅读
目的:分析拉舒利迭联合无创机械通气(Bi PAP)治疗老年慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭的临床价值。方法:选取我院2014年收治的90例老年COPD合并Ⅱ型呼吸衰竭患者,按照不同的治疗方式,分为观察组与对照组。观察组采用舒利迭联合Bi PAP治疗,对照组单独采用Bi PAP治疗,观察两组治疗前后的动脉血气指标变化情况和临床病症积分,对比两组的治疗效果。结果:经治疗后,观察组临床病症积分显著降低,且优于对照组(P<0.05);观察组动脉血气各项指标改善情况优于对照组(P<0.05);观察组治疗总有效率为93.33%明显高于对照组的71.11%(P<0.05)。结论:采用舒利迭联合Bi PAP治疗老年COPD合并Ⅱ型呼吸衰竭,可以改善患者的临床症状和动脉血气,具有较高的临床应用价值。
Objective: To analyze the clinical value of laurethilian combined with noninvasive mechanical ventilation (Bi PAP) in the treatment of senile chronic obstructive pulmonary disease (COPD) with type Ⅱ respiratory failure. Methods: Ninety elderly COPD patients with type Ⅱ respiratory failure admitted in our hospital in 2014 were divided into observation group and control group according to different treatment methods. The observation group was treated with Seretide combined with Bi PAP. The control group was treated with Bi PAP alone. Changes of arterial blood gas index and clinical symptom scores before and after treatment were observed. The therapeutic effects were compared between the two groups. Results: After treatment, the scores of clinical symptoms in the observation group were significantly lower than those in the control group (P <0.05); the improvement of arterial blood gas in the observation group was better than that in the control group (P <0.05); the total effective rate 93.33% was significantly higher than the control group 71.11% (P <0.05). Conclusion: The combination of seretide and Bi PAP in the treatment of senile COPD with type Ⅱ respiratory failure can improve the clinical symptoms and arterial blood gas, and has a high clinical value.